Amid global expansion, Samsung Biologics pledges emissions drops in new ESG report
As the biotech manufacturing arm of one of Korea’s largest conglomerates is aiming to rapidly expand its global presence after a large investment by its parent, Samsung Biologics is also keeping a close eye on environmental, social and governance (ESG) goals.
Its second ESG report breaks down the company’s goals for renewable energy in future projects as well as a bigger commitment to reduce emissions.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.